Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled Study | Zendy

Henry G. Bone | Zendy; R. Lindsay | Zendy; Michael R. McClung | Zendy; Alfonso T. Perez | Zendy; Marsha G. Raanan | Zendy; Robert G. Spanheimer | Zendy

Open Access

Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled Study

Author(s) -

Henry G. Bone,

R. Lindsay,

Michael R. McClung,

Alfonso T. Perez,

Marsha G. Raanan,

Robert G. Spanheimer

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-4096

Subject(s) - pioglitazone , medicine , placebo , endocrinology , bone mineral , type 2 diabetes , diabetes mellitus , bone density , glycemic , femoral neck , bone remodeling , urology , osteoporosis , alternative medicine , pathology

Meta-analyses of clinical studies have suggested an increased incidence of peripheral fractures in postmenopausal women with type 2 diabetes mellitus taking pioglitazone. The mechanism behind this apparent increase is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research